Ohio SB160 regulates prescription drug cost-sharing and substitution in health benefit plans.

Ohio SB160 prohibits health plan issuers from increasing cost-sharing for drugs, moving drugs to more restrictive tiers, or requiring substitutions of epinephrine autoinjectors without proper justification. It also prevents plans from limiting coverage of drugs in ways that could disadvantage patients. The bill does not prevent plans from adding or removing drugs from their formularies under certain conditions, such as FDA safety concerns or manufacturer discontinuance. Violations of these provisions are considered unfair and deceptive practices.

Ohio SB160 regulates prescription drug cost-sharing and substitution in health benefit plans.

Ohio SB160 prohibits health plan issuers from increasing cost-sharing for drugs, moving drugs to more restrictive tiers, or requiring substitutions of epinephrine autoinjectors without proper justification. It also prevents plans from limiting coverage of drugs in ways that could disadvantage patients. The bill does not prevent plans from adding or removing drugs from their formularies under certain conditions, such as FDA safety concerns or manufacturer discontinuance. Violations of these provisions are considered unfair and deceptive practices.